Nov 14 (Reuters) - Annexin Pharmaceuticals AB (publ)
ANNX.ST :
* ANNEXIN GRANTED ADDITIONAL PATENT PROTECTION IN THE US
* IN ADDITION, USPTO GRANTS AN EXTENSION OF PATENT
PROTECTION TO
2039
* DRUG CANDIDATE ANXV HAS BEEN GRANTED ENHANCED, EXTENDED
PATENT
PROTECTION BY US PATENT AND TRADEMARK OFFICE
* USPTO GRANTS AN EXTENSION OF PATENT PROTECTION TO 2039
Source text for Eikon: ID:nMFN7GcYM1
Further company coverage: ANNX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))